Treatment efficacy and safety in elderly genotype 1b chronic hepatitis C patients with high viral load
Nishikawa, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 209-213
2015
ISSN/ISBN: 0047-1852 PMID: 26845932 Document Number: 679835
Document emailed within 1 workday
Related Documents
Nakamura, H.; Ogawa, H.; Kuroda, T.; Yamamoto, M.; Enomoto, H.; Kishima, Y.; Yoshida, K.; Ito, H.; Matsuda, M.; Noguchi, S. 2002: Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus Hepato-Gastroenterology 49(47): 1373-1376Ma, L.-n.; Chen, X.-y.; Chen, J.; Shen, C.-l.; Wang, J.-t. 2006: Efficacy, influencing factors and safety of PEG-INF alpha-2a (PEG-INF-2a) in the treatment of chronic hepatitis C: analysis of 89 patients Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 20(2): 42-45
Karoui, S.; Ben Romdhane, S.; Serghini, M.; Ben Mustapha, N.; Boubaker, J.; Haouet, S.; Filali, A. 2012: Is APRi score a suitable tool for prediction of fibrosis in Tunisian patients with genotype 1 chronic viral hepatitis C? La Tunisie Medicale 90(4): 282-285
Trapero, M.; García-Buey, L.; Muñoz, C.; Vitón, M.; Moreno-Monteagudo, J.A.; Borque, M.J.; Quintana, N.E.; Moreno-Otero, R. 2005: Maintenance of T1 response as induced during PEG-IFNalpha plus ribavirin therapy controls viral replication in genotype-1 patients with chronic hepatitis C Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 97(7): 481-490
Hrstić, I.; Ostojić, R. 2013: Treatment of non-1 genotype chronic hepatitis C patients Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 67(4): 339-343
Amegeiras, B.; González, J.E.; Jotimliansky, L.; Zingoni, C.; Vulcano, C. 2013: Viral load survey from geographical areas within Argentina with high hepatitis B virus prevalence Acta Gastroenterologica Latinoamericana 43(1): 16-21
Azevedo, H.A.; Villela-Nogueira, C.A.; Perez, R.M.; Segadas-Soares, J.A.; Takahashi, C.; Gaburo, N.; Pessoa, I.; Coelho, H.Sérgio.M. 2007: Similar HCV viral load levels and genotype distribution among end-stage renal disease patients on hemodialysis and HCV-infected patients with normal renal function Journal of Nephrology 20(5): 609-616
Jian, Z.-j.; Zhou, B.-y. 2008: Efficacy and safety of acarbose in the treatment of elderly patients with postprandial hypotension Chinese Medical Journal 121(20): 2054-2059
Xu, J.-h.; Yu, Y.-y.; Si, C.-w.; Chen, X.-y.; Han, Z.-h.; Chen, Y.; Li, X.-y. 2009: A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment Zhonghua Yi Xue Za Zhi 89(41): 2902-2905
Techapaitoon, S. 1999: Efficacy of high dose interferon--alpha treatment of chronic hepatitis B Journal of the Medical Association of Thailand 82(11): 1118-1126
Tseng, T-Chung.; Liu, C-Jen.; Wang, C-Chi.; Chen, P-Jer.; Lai, M-Yang.; Chen, D-Shinn.; Kao, J-Horng. 2009: Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels Antiviral Therapy 14(2): 203-210
Ikeda, F.; Yamamoto, K.; Iwasaki, Y. 2011: Treatment of elderly patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 221-226
Zhang, L.-d.; Zhang, H.-m.; Pei, J.; He, G.-r.; Sun, X.-f.; Li, B. 2007: Investigation on HPV viral load and high risk HPV types infection among patients with infertility Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 21(2): 159-161
Stamouli, M.; Panagiotou, I.; Kairis, D.; Michopoulou, A.; Skliris, A.; Totos, G. 2012: Genotype Distribution in Chronic Hepatitis C Patients in Greece Clinical Laboratory 58(1-2): 173-176
Kokoreva, L.N.; Zmyzgova, A.V.; Shalygina, N.B. 1996: The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results Terapevticheskii Arkhiv 68(2): 10-14
Pol, S. 2002: Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance Gastroenterologie Clinique et Biologique 26(Special Issue 2): B264-B273
Varghese, R.; Al-Khaldi, J.; Asker, H.; Fadili, A.A.; Al Ali, J.; Hassan, F.A. 2009: Treatment of chronic hepatitis C genotype 4 with peginterferon alpha-2a plus ribavirin Hepato-Gastroenterology 56(89): 218-222
Kepa, L.; Mossor, K.; Beniowski, M.; Miczek, J. 1985: Viral hepatitis in elderly patients (over 65 years of age) Polski Tygodnik Lekarski 40(30): 841-844
Ashour, E.; Samy, N.; Sayed, M.; Imam, A. 2010: The Relationship Between Serum Adiponectin and Steatosis in Patients with Chronic Hepatitis C Genotype-4 Clinical Laboratory 56(3-4): 103-110
Zielińska, W.; Korczak-Rogoń, A.; Paszkiewicz, J.; Kowalik, M.; Cummins, J.M.; Georgiades, J.A. 1996: Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients Archivum Immunologiae et Therapiae Experimentalis 44(5-6): 359-366